Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01176253 · ClinicalTrials.gov registry record
Detection of Human Beta Cell Death in Type 1 Diabetes Mellitus (T1DM) by Methylation Specific Polymerase Chain Reaction (PCR)
A clinical trial, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 6
- Enrollment target
NCT01176253 is a clinical trial that has completed, run by City of Hope Medical Center. The registered enrollment target is 6 participants.
The verdict
NCT01176253 has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
To investigate the use of methylation-specific PCR (MSP) assays to detect human beta cell-specific gene methylation patterns in serial blood samples drawn from newly diagnosed Type 1 diabetics.
Interventions
- PROCEDURE Blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-07 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01176253
The ClinicalTrials.gov registry entry for NCT01176253 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood draw is the first listed.
NCT01176253 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01176253 about?
NCT01176253 is a clinical study titled "Detection of Human Beta Cell Death in Type 1 Diabetes Mellitus (T1DM) by Methylation Specific Polymerase Chain Reaction (PCR)". To investigate the use of methylation-specific PCR (MSP) assays to detect human beta cell-specific gene methylation patterns in serial blood samples drawn from newly diagnosed Type 1 diabetics.
What is the current status of trial NCT01176253?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2009-07. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01176253?
The interventions under investigation include: Blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT01176253?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.